Nemocnice Novy Jicin a.s.
About Nemocnice Novy Jicin a.s.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
4
Bristol-Myers Squibb
2
VectivBio AG
2
EMD Serono Research & Development Institute, Inc.
1
Ferring Pharmaceuticals
1
Fresenius Kabi SwissBioSim GmbH
1
Hoffmann-La Roche
1
Janssen Research & Development, LLC
1
Janssen Scientific Affairs, LLC
1
Jiangsu HengRui Medicine Co., Ltd.
1
NovoCure Ltd.
1
Clinical Trials at Nemocnice Novy Jicin a.s.
During the past decade, Nemocnice Novy Jicin a.s. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients
2011-09-01
2013-04-01
Completed
659
A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting
2013-03-29
2019-12-09
Completed
621
A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent Asthma
2014-02-28
2016-12-20
Completed
230
A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC
2015-04-01
2017-12-01
Completed
719
Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)
2015-03-24
2019-12-03
Completed
792
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Nemocnice Novy Jicin a.s." #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Bristol-Myers Squibb" with 2 trials
sponsored, "VectivBio AG" with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Ferring Pharmaceuticals"
with 1 trials sponsored. Other sponsors include 5 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Nemocnice Novy Jicin a.s."
#1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Fresenius Medical Care North America" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Nemocnice Novy Jicin a.s.
According to Clinical.Site data, the most researched conditions in "Nemocnice Novy Jicin a.s." are
"Psoriasis" (6 trials), "Atopic Dermatitis" (3 trials), "Short Bowel Syndrome" (2 trials), "Asthma" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Nemocnice Novy Jicin a.s." in a lesser frequency.
Clinical Trials Intervention Types at Nemocnice Novy Jicin a.s.
Most popular intervention types in "Nemocnice Novy Jicin a.s." are "Drug" (18 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Baricitinib" (3 trials), "BMS-986165" (2 trials), "Apraglutide" (1 trials) and "Apremilast" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Nemocnice Novy Jicin a.s.
The vast majority of trials in "Nemocnice Novy Jicin a.s." are
18 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Nemocnice Novy Jicin a.s.
Currently, there are NaN active trials in "Nemocnice Novy Jicin a.s.".
undefined are not yet recruiting,
5 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Nemocnice Novy Jicin a.s.,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Nemocnice Novy Jicin a.s., 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Nemocnice Novy Jicin a.s.
Nemocnice Novy Jicin a.s. has several departments that took part in Clinical trials: "Nemocnice AGEL Novy Jicin a.s.; Oddeleni radioterapie a onkologie" - 3 trials
Departments List
Name
City
Trials